We are live on ! Find out more
DCOY

Decoy Therapeutics
DCOY

1 hedge funds and large institutions have $697K invested in Decoy Therapeutics in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (0%)

35% less capital invested

Capital invested by funds: $1.07M → $697K (-$373K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$165K
2
WS
Wedbush Securities
California
-$30K
3
BIM
Baldwin Investment Management
Pennsylvania
-$10K
4
Bank of America
Bank of America
North Carolina
-$3K

DCOY Hedge Fund Activity: Q4 2018 in Review

1 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Decoy Therapeutics (DCOY) for Q4 2018, worth a combined $697K — down 35% from $1.07M a quarter earlier.

Fund positioning in DCOY was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Deutsche Bank, cutting an estimated $165K.

  • 1 institutional investor held Decoy Therapeutics (DCOY) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $697K of Decoy Therapeutics stock for Q4 2018, down 35% quarter-over-quarter.
  • 0 funds opened new Decoy Therapeutics positions in Q4 2018 and 0 closed out.
  • The largest Decoy Therapeutics seller in Q4 2018 was Deutsche Bank, an estimated $165K sold.

Based on aggregated 13F filings for Q4 2018.